News & Events

 
August 06, 2018
Cesca Therapeutics to Announce Financial Results for the Second Quarter Ended June 30, 2018 and Host Conference Call on August 13
 
July 16, 2018
Cesca Therapeutics Announces the Launch of its PXP™ System for Automated Processing of Bone Marrow Cells
 
June 6, 2018
Cesca Therapeutics Announces Exhibition at The Orthobiologic Institute’s 9th Annual PRP & Regenerative Medicine Symposium
 
June 4, 2018
Cesca Therapeutics Announces Reduction in Operating Expenses
 
May 23, 2018
Cesca Therapeutics’ Chief Technology Officer, Phil Coelho, Provides Deep Dive into the CAR-T Manufacturing Process in Cell & Gene Therapy
 
May 18, 2018
Cesca Announces Closing of $5.5 Million Public Offering
 
May 16, 2018
Cesca Prices $5.5 Million Public Offering
 
May 14, 2018
Cesca Therapeutics Announces First Quarter 2018 Financial Results and Provides Corporate Update
 
May 9, 2018
Cesca Therapeutics to Announce Financial Results for the First Quarter Ended March 31, 2018 and Host Conference Call on May 14
 
May 4, 2018
Cesca Therapeutics Inc. Presents New Data on its Proprietary X-Series™ Cellular Processing Systems
 
April 25, 2018
Cesca Therapeutics Inc. to Exhibit at Several Upcoming Cell Therapy Conferences
 
April 24, 2018
Cesca Therapeutics Announces Evaluation Agreement With The University Of North Carolina Lineberger Advanced Cellular Therapeutics Facility for X-Series™ Products That Provide Automated, Closed System Cellular Processing
 
April 17, 2018
Cesca Therapeutics Announces First Evaluation Agreement With a Leading U.S. Academic Research Institution for X-Series™ Products That Provide Automated, Closed System Cellular Processing
 
April 3, 2018
Cesca Therapeutics Inc. Announces Release of X-Mini™ Cell Selection Kit for the CAR-T Research Market
 
TotipotentRX Cell Therapy Pvt. Ltd.
312A, Suncity Success Tower, Sec - 65, Gurugram - 122001, Haryana, India.
Tel.: +91 124 2841360/1361